Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03322865
Title Obinutuzumab in Marginal Zone Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christian Buske
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Augusta-Kranken-Anstalt gGmbH Bochum 44791 Germany Details
ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing Dingolfing 84113 Germany Details
University Hospital Essen Essen 45147 Germany Details
Universitätsklinikum Freiburg Freiburg 79106 Germany Details
Universitätsmedizin Georg-August-University Göttingen 37075 Germany Details
University Hospital Halle Halle (Saale) 06120 Germany Details
University Hospital Kiel Kiel 24105 Germany Details
Institut für Versorgungsforschung GbR Koblenz 56068 Germany Details
ÜBAG MVZ Dr. Vehling-Kaiser GmbH Landshut 84036 Germany Details
University Hospital Mainz Mainz 55101 Germany Details
Universitätsklinikum Mannheim Mannheim 68167 Germany Details
Gemeinschaftspraxis für Hämatologie und Onkologie Münster 48149 Germany Details
University Hospital Münster Münster 48149 Germany Details
Pius-Krankenhaus Oldenburg, Medizinischer Campus Universität Oldenburg Oldenburg 26121 Germany Details
Klinikum Passau Passau 94032 Germany Details
University Hospital Ulm Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from for the field